Manganese neurotoxicity: lessons learned from longitudinal studies in nonhuman primates
- PMID: 19337503
- PMCID: PMC2661898
- DOI: 10.1289/ehp.0800035
Manganese neurotoxicity: lessons learned from longitudinal studies in nonhuman primates
Abstract
Background: Exposure to excess levels of the essential trace element manganese produces cognitive, psychiatric, and motor abnormalities. The understanding of Mn neurotoxicology is heavily governed by pathologic and neurochemical observations derived from rodent studies that often employ acute Mn exposures. The comparatively sparse studies incorporating in vivo neuroimaging in nonhuman primates provide invaluable insights on the effects of Mn on brain chemistry.
Objectives: The purpose of this review is to discuss important aspects of Mn neurotoxicology and to synthesize recent findings from one of the largest cohorts of nonhuman primates used to study the neurologic effects of chronic Mn exposure.
Discussion: We reviewed our recent in vivo and ex vivo studies that have significantly advanced the understanding of Mn-induced neurotoxicity. In those studies, we administered weekly doses of 3.3-5.0 (n=4), 5.0-6.7 (n=5), or 8.3-10.0 mg Mn/kg (n=3) for 7-59 weeks to cynomolgus macaque monkeys. Animals expressed subtle deficits in cognition and motor function and decreases in the N-acetylaspartate-to-creatine ratio in the parietal cortex measured by magnetic resonance spectroscopy reflective of neuronal dysfunction. Impaired striatal dopamine release measured by positron emission tomography was observed in the absence of changes in markers of dopamine neuron degeneration. Neuropathology indicated decreased glutamine synthetase expression in the globus pallidus with otherwise normal markers of glutamatergic and GABAergic neurotransmission. Increased amyloid beta (A4) precursor-like protein 1 gene expression with multiple markers of neurodegeneration and glial cell activation was observed in the frontal cortex.
Conclusions: These findings provide new information on mechanisms by which Mn affects behavior, neurotransmitter function, and neuropathology in nonhuman primates.
Keywords: Parkinson disease; cognitive function; dopamine; manganese; neurodegeneration; neurotoxicity; non human primates; positron emission tomography.
Similar articles
-
Effects of chronic manganese exposure on glutamatergic and GABAergic neurotransmitter markers in the nonhuman primate brain.Toxicol Sci. 2009 Sep;111(1):131-9. doi: 10.1093/toxsci/kfp124. Epub 2009 Jun 10. Toxicol Sci. 2009. PMID: 19520674 Free PMC article.
-
Evidence for cortical dysfunction and widespread manganese accumulation in the nonhuman primate brain following chronic manganese exposure: a 1H-MRS and MRI study.Toxicol Sci. 2006 Dec;94(2):351-8. doi: 10.1093/toxsci/kfl106. Epub 2006 Sep 12. Toxicol Sci. 2006. PMID: 16968886
-
Pathophysiology of manganese-associated neurotoxicity.Neurotoxicology. 2012 Aug;33(4):881-6. doi: 10.1016/j.neuro.2011.12.010. Epub 2011 Dec 21. Neurotoxicology. 2012. PMID: 22202748 Free PMC article.
-
Adequacy and consistency of animal studies to evaluate the neurotoxicity of chronic low-level manganese exposure in humans.J Toxicol Environ Health A. 2007 Apr 1;70(7):594-605. doi: 10.1080/10937400600882897. J Toxicol Environ Health A. 2007. PMID: 17365613 Review.
-
Manganese and Parkinson's disease: a critical review and new findings.Environ Health Perspect. 2010 Aug;118(8):1071-80. doi: 10.1289/ehp.0901748. Epub 2010 Apr 19. Environ Health Perspect. 2010. PMID: 20403794 Free PMC article. Review.
Cited by
-
CYP1B1 affects the integrity of the blood-brain barrier and oxidative stress in the striatum: An investigation of manganese-induced neurotoxicity.CNS Neurosci Ther. 2024 Mar;30(3):e14633. doi: 10.1111/cns.14633. CNS Neurosci Ther. 2024. PMID: 38429921 Free PMC article.
-
Butyrate Protects and Synergizes with Nicotine against Iron- and Manganese-induced Toxicities in Cell Culture.Neurotox Res. 2023 Dec 14;42(1):3. doi: 10.1007/s12640-023-00682-z. Neurotox Res. 2023. PMID: 38095760
-
Butyrate protects and synergizes with nicotine against iron- and manganese-induced toxicities in cell culture: Implications for neurodegenerative diseases.Res Sq [Preprint]. 2023 Oct 5:rs.3.rs-3389904. doi: 10.21203/rs.3.rs-3389904/v1. Res Sq. 2023. Update in: Neurotox Res. 2023 Dec 14;42(1):3. doi: 10.1007/s12640-023-00682-z. PMID: 37886507 Free PMC article. Updated. Preprint.
-
The HSP40 chaperone Ydj1 drives amyloid beta 42 toxicity.EMBO Mol Med. 2022 May 9;14(5):e13952. doi: 10.15252/emmm.202113952. Epub 2022 Apr 4. EMBO Mol Med. 2022. PMID: 35373908 Free PMC article.
-
Manganese Encephalopathy Caused by Homemade Methcathinone (Ephedrone) Prevalence in Poland.Nutrients. 2021 Oct 3;13(10):3496. doi: 10.3390/nu13103496. Nutrients. 2021. PMID: 34684497 Free PMC article.
References
-
- Agency for Toxic Substances and Disease Registry. Toxicological Profile for Manganese. 2000. [[accessed 1 June 2008]]. Available: http://www.atsdr.cdc.gov/toxprofiles/tp151.html. - PubMed
-
- Aggarwal A, Vaidya S, Shah S, Singh J, Desai S, Bhatt M. Reversible parkinsonism and T1W pallidal hyperintensities in acute liver failure. Mov Disord. 2006;21:1986–1990. - PubMed
-
- Alves G, Thiebot J, Tracqui A, Delangre T, Guedon C, Lerebours E. Neurologic disorders due to brain manganese deposition in a jaundiced patient receiving long-term parenteral nutrition. JPEN J Parenter Enteral Nutr. 1997;21:41–45. - PubMed
-
- Archibald FS, Tyree C. Manganese poisoning and the attack of trivalent manganese upon catecholamines. Arch Biochem Biophys. 1987;256:638–650. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials